Our top pick for
Arhaus Inc is a home improvement retail business based in the US. Arhaus shares (ARHS) are listed on the NASDAQ and all prices are listed in US Dollars. Arhaus employs 1,620 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$5.02|
|52-week range||$4.88 - $14.95|
|50-day moving average||$6.37|
|200-day moving average||$8.39|
|Wall St. target price||$12.38|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.27|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-06-22)||-7.21%|
|1 month (2022-06-01)||-13.00%|
|3 months (2022-04-01)||-41.22%|
|6 months (2021-12-31)||-62.11%|
|1 year (2021-06-27)||N/A|
|2 years (2020-06-27)||N/A|
|3 years (2019-06-27)||N/A|
|5 years (2017-06-27)||N/A|
Valuing Arhaus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Arhaus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Arhaus's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 21x. In other words, Arhaus shares trade at around 21x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Arhaus's P/E ratio is best considered in relation to those of others within the home improvement retail industry or those of similar companies.
Arhaus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $80.4 million.
The EBITDA is a measure of a Arhaus's overall financial performance and is widely used to measure a its profitability.
To put Arhaus's EBITDA into context you can compare it against that of similar companies.
|Revenue TTM||$871.9 million|
|Operating margin TTM||6.32%|
|Gross profit TTM||$329.9 million|
|Return on assets TTM||5.98%|
|Return on equity TTM||168.04%|
|Market capitalisation||$802.6 million|
TTM: trailing 12 months
We're not expecting Arhaus to pay a dividend over the next 12 months.
You may also wish to consider:
Arhaus, Inc. operates as a lifestyle brand and premium retailer in the home furnishings market. It provides merchandise assortments across various categories, including furniture, lighting, textiles, décor, and outdoor. The company's furniture products comprise bedroom, dining room, living room, and home office furnishings, which includes sofas, dining tables and chairs, accent chairs, console and coffee tables, beds, headboards, dressers, desks, bookcases and modular storage, etc. ; and outdoor products include outdoor dining tables, chairs, chaises and other furniture, lighting, textiles, décor, umbrellas, and fire pits. It also offers lighting products, such as various distinct and artistic lighting fixtures, including chandeliers, pendants, table and floor lamps, and sconces; textile products comprising handcrafted indoor and outdoor rugs, bed linens, and pillows and throws; and décor products, including various wall art to mirrors, vases to candles, and other decorative accessories. The company distributes its products through an omni-channel model comprising showrooms, e-commerce platform, catalog, and in-home designer services.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.